← Back to contracts

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

US · MD Dept › of the Army -- USAMRAA (U › S › Army Medical Research Acquisition Activity) grant open #HT942526BCRPBTA12
Response due Jul 08, 2026 · 00:00 UTC

Summary

The Department of Defense (DoD), through the U.S. Army Medical Research Acquisition Activity (USAMRAA), is soliciting applications for the Breakthrough Award Levels 1 and 2 under the Department of Defense (DoW) Breast Cancer Research Program (BCRP). This grant opportunity funds innovative breast cancer research at two distinct breakthrough award levels. The program is administered via Grants.gov and is consistent with DoD's congressionally directed medical research mission. No additional scope details are provided in the synopsis.

How they evaluate

Submission: Grants.gov electronic submission portal

Risks & flags

  • Extremely limited scope detail in synopsis — no research focus areas, eligibility criteria, or award dollar amounts disclosed, making competitive assessment difficult
  • Short description with no attachments or program announcement referenced — full Program Announcement may contain restrictive eligibility requirements not yet visible

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541714
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

DoW Breast Cancer, Breakthrough Award Leve…
Due Jul 08
Onboard